World's Best Scientists 2026 revealed!
Kazuyuki Yoshizaki

Kazuyuki Yoshizaki

D-Index & Metrics

Immunology

D-Index
70
Citations
25778
World Ranking
2375
National Ranking
88

Kazuyuki Yoshizaki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazuyuki Yoshizaki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 194 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazuyuki Yoshizaki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuyuki Yoshizaki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazuyuki Yoshizaki is affiliated with Osaka University in Japan and has contributed extensively to the field of medicine. Their research primarily addresses infectious diseases, neurology, oncology, pathology and forensic medicine, and physiology. The scientist's work encompasses 36 publications within medicine, with notable subfields including infectious diseases (12 publications), neurology (7 publications), oncology (6 publications), pathology and forensic medicine (5 publications), and physiology (2 publications).

Their study topics cover several important areas such as COVID-19 clinical research studies and its long-term effects, viral-associated cancers and disorders, lymphoma diagnosis and treatment, SARS-CoV-2 and COVID-19 research, histiocytic disorders and treatments, and eosinophilic disorders and syndromes. This illustrates a focus on both infectious conditions and complex immune-related disorders.

Recent publications by Kazuyuki Yoshizaki include:

  • International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease (2020, Blood Advances)
  • Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease (2021, American Journal of Hematology)
  • Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein (2022, Scientific Reports)
  • Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19 (2021, Frontiers in Medicine)
  • Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease (2023, Nature Communications)

Kazuyuki Yoshizaki has collaborated frequently with several coauthors, including Kazuko Uno (7 publications), Emi E. Nakayama (6 publications), Toshio Tanaka (6 publications), Tatsuo Shioda (6 publications), and Shoji Hashimoto (5 publications). These collaborations highlight an active engagement in multi-author research projects.

The scientist has published in a variety of venues, reflecting the multidisciplinary nature of their research. Frequently targeted journals and platforms include:

  • Scientific Reports (2 publications)
  • Journal of Veterinary Medical Science (2 publications)
  • Research Square (2 publications)
  • Blood Advances (1 publication)
  • American Journal of Hematology (1 publication)

Best Publications

  • Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

    R Atreya;J Mudter;S Finotto;J Müllberg

  • Structure and function of a new STAT-induced STAT inhibitor

    Tetsuji Naka;Masashi Narazaki;Moritoshi Hirata;Tomoshige Matsumoto

  • Pathogenic Significance of Interleukin-6 (IL-6/BSF-2) in Castleman's Disease

    K Yoshizaki;T Matsuda;N Nishimoto;T Kuritani

  • Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

    Norihiro Nishimoto;Kazuyuki Yoshizaki;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

    Norihiro Nishimoto;Yuzuru Kanakura;Katsuyuki Aozasa;Takeshi Johkoh

  • A pilot randomized Trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

    Hiroaki Ito;Masakazu Takazoe;Yoshihiro Fukuda;Toshifumi Hibi

  • TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

    Christoph Becker;Massimo C. Fantini;Christoph Schramm;Hans A. Lehr

  • Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

    Ernest Choy;D A Isenberg;Toby Garrood;S Farrow

  • Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

    Norihiro Nishimoto;Norihiro Nishimoto;Mitsuko Sasai;Mitsuko Sasai;Yoshihito Shima;Yoshihito Shima;Masashi Nakagawa;Masashi Nakagawa

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis

    Mitsunari Yamamoto;Kazuyuki Yoshizaki;Tadamitsu Kishimoto;Hiroaki Ito

  • Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis.

    Shumpei Yokota;Takako Miyamae;Tomoyuki Imagawa;Naomi Iwata

  • Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

    Hideko Nakahara;Jian Song;Masamichi Sugimoto;Keisuke Hagihara

  • Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

    Shigeaki Ohno;Satoshi Nakamura;Sadao Hori;Machiko Shimakawa

  • Hypoxic stress induces cardiac myocyte-derived interleukin-6

    Keiko Yamauchi-Takihara;Yoshiji Ihara;Atsushi Ogata;Kazuyuki Yoshizaki

  • Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

    Nobuhiro Takagi;Masahiko Mihara;Yoichiro Moriya;Norihiro Nishimoto

  • International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Frits Van Rhee;Peter Voorhees;Angela Dispenzieri;Alexander Fosså

  • The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo

    Aysefa Doganci;Tatjana Eigenbrod;Norbert Krug;George T. De Sanctis

  • Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells.

    Y Horii;A Muraguchi;S Suematsu;T Matsuda

  • Blockade of Interleukin-6 Receptor Suppresses Reactive Astrogliosis and Ameliorates Functional Recovery in Experimental Spinal Cord Injury

    Seiji Okada;M. Nakamura;Y. Mikami;T. Shimazaki

  • TGF-beta suppresses tumor progression in colon cancer by inhibition of IL–6 trans-signaling

    C Becker;MC Fantini;C Schramm;HA Lehr

Frequent Co-Authors

Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Norihiro Nishimoto
Norihiro Nishimoto Osaka University
Masahiro Iwamoto
Masahiro Iwamoto University of Maryland, Baltimore
Yuichi Yamamura
Yuichi Yamamura Osaka University
Stefan Rose-John
Stefan Rose-John Kiel University
Yoshiyuki Ohsugi
Yoshiyuki Ohsugi Roche (Switzerland)
Markus F. Neurath
Markus F. Neurath University of Erlangen-Nuremberg
Junichi Azuma
Junichi Azuma Osaka University
Satoshi Kimura
Satoshi Kimura University of Tokyo
Hideyuki Okano
Hideyuki Okano Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, several related online degrees can expand career opportunities in healthcare and research. One growing field is psychiatric nursing, with affordable options available through the cheapest online pmhnp programs. These programs prepare graduates to specialize in mental health, complementing immunology knowledge when addressing psychoneuroimmunology.

Nursing professionals pursuing advanced practice roles may consider salary prospects to guide their education choices. Understanding how much do dnp nurses make can help in selecting the right degree and specialization path based on regional demand and compensation.

For those already certified as Family Nurse Practitioners, transitioning to acute care settings is a strategic option. Enrolling in an fnp to acnp bridge program online provides flexible pathways to broaden clinical expertise and work with immunocompromised patients.

Additionally, accelerated routes like the accelerated np programs offer efficient options to complete Nurse Practitioner education online. These programs cater to career changers and fast-track learners seeking to enter advanced practice sooner.

Best Scientists Citing Kazuyuki Yoshizaki

Trending Scientists

Recently Published Articles